Angel Pablos-De
Sevilla, AN 41009, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Myeloperoxidase and Advanced Oxidation Protein Products in the Cerebrospinal Fluid in Women and Men with Parkinson's Disease.
Journal: Antioxidants (Basel, Switzerland)
Published: April 30, 2022
Cerebrospinal fluid lactoperoxidase level is enhanced in idiopathic Parkinson's disease, and correlates with levodopa equivalent daily dose.
Journal: Brain research
Published: October 03, 2020
Effect of an individualized versus standard pneumoperitoneum pressure strategy on postoperative recovery: a randomized clinical trial in laparoscopic colorectal surgery.
Journal: The British journal of surgery
Published: March 12, 2020
Analysis of neurotrophic and antioxidant factors related to midbrain dopamine neuronal loss and brain inflammation in the cerebrospinal fluid of the elderly.
Journal: Experimental gerontology
Published: November 18, 2017
Does the Cerebrospinal Fluid Reflect Altered Redox State But Not Neurotrophic Support Loss in Parkinson's Disease?
Journal: Antioxidants & redox signaling
Published: August 12, 2015
May the thyroid gland and thyroperoxidase participate in nitrosylation of serum proteins and sporadic Parkinson's disease?
Journal: Antioxidants & redox signaling
Published: August 16, 2014
May the evaluation of nitrosative stress through selective increase of 3-nitrotyrosine proteins other than nitroalbumin and dominant tyrosine-125/136 nitrosylation of serum α-synuclein serve for diagnosis of sporadic Parkinson's disease?
Journal: Antioxidants & redox signaling
Published: February 20, 2013
May serum levels of advanced oxidized protein products serve as a prognostic marker of disease duration in patients with idiopathic Parkinson's disease?
Journal: Antioxidants & redox signaling
Published: November 06, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026